Ali Faraz
Chief Executive Officer
Ali Faraz has filed 6 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Sep 12, 2026.
On the most recent filing, Ali Faraz is listed as Chief Executive Officer at Tenaya Therapeutics, Inc. Inside the rolling window, Ali Faraz reported no open-market purchases and 4 open-market sales totaling $32K in TNYA. The largest disclosed transaction in the window is a sale of 22,232 TNYA shares on Aug 17, 2026, worth $16K.
Companies traded
Other insiders at TNYA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$32K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Ali Faraz made?
Ali Faraz has filed 6 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.
Which companies does Ali Faraz trade?
Ali Faraz has filed SEC Form 4 disclosures for 1 company, including TNYA.
When was Ali Faraz's most recent SEC Form 4 filing?
Ali Faraz's most recent SEC Form 4 filing on Tracefour is dated Sep 12, 2026.
What is Ali Faraz's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Ali Faraz is listed as Chief Executive Officer.
What is Ali Faraz's total buy and sell value in the current window?
Inside the rolling retention window, Ali Faraz bought $0 and sold $32K based on SEC Form 4 filings.
What was Ali Faraz's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 22,232 TNYA shares on 2026-08-17, worth $16K, per SEC Form 4 filings.